Skip to main content
SpringerLink
Log in

Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine

  • Original Contributions
  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Cardiac toxicity has been associated with HIV infection and exposure to nucleoside reverse transcriptase inhibitors (NRTIs), but the role of the latter in the development of cardiac disease of HIV-infected patients is uncertain. To investigate the cardiotoxicity of transplacentally administered zidovudine (AZT) or AZT plus lamivudine (3TC) in the absence of HIV infection, we evaluated several biomarkers of cardiac mitochondrial structure and cardiac structure and function in a B6C3F1 mouse model. In utero exposure to AZT-3TC resulted in ultrastructural pathology, loss of mitochondria, and altered echocardiographic measurements in newborn mice. Cardiac pathology and dysfunction persisted into the adult life of female mice exposed in utero to AZT, as evidenced by significant dose-dependent heart enlargement, clusters of atypical mitochondria and myofibril alterations, significantly increased cytochrome c oxidase activity, and significantly higher numbers of mutations in mitochondrial tRNA genes compared with unexposed controls at 18 to 24 mo of age. These data led to the hypothesis that the long-term pathology of perinatal exposure to these NRTIs is related to persistent mitochondrial DNA mutations in cardiac tissue; that is, the primary damage during drug treatment is mutational (as opposed to affecting polymerase γ and/or other mitochondrial elements) and leads over time to delayed, progressive cardiotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jacob, A.J., Sutherland, G.R., Bird, A.G., Brettle, R.P., Ludlam, C.A., McMillan, A., et al. (1992). Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br. Heart. J. 68:549–553.

    PubMed  CAS  Google Scholar 

  2. Roy, V.P., Prabhakar, S., Pulvirenti, J., and Mathew, J. (1999). Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital. J. Natl. Med. Assoc. 91: 502–504.

    PubMed  CAS  Google Scholar 

  3. Currie, P.F. and Boon, N.A. (2003). Immunopathogenesis of HIV-related heart muscle disease: current perspectives. AIDS 17(Suppl 1):S21-S28.

    PubMed  Google Scholar 

  4. Cossarizza, A., Troiano, L., and Mussini, C. (2002). Mitochondria and HIV infection: the first decade. J. Biol. Regul. Homeost. Agents 16:18–24.

    PubMed  CAS  Google Scholar 

  5. Lewis, W., Haase, C.P., Raidel, S.M., Russ, R.B., Sutliff, R.L., Hoit, B.D., et al. (2001). Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice. Lab. Invest. 81:1527–1536.

    PubMed  CAS  Google Scholar 

  6. d'Amati, G. and Lewis, W. (1994). Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells. Lab. Invest. 71:879–884.

    PubMed  Google Scholar 

  7. Lim, S.E. and Copeland, W.C. (2001). Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J. Biol. Chem. 276:23616–23623.

    Article  PubMed  CAS  Google Scholar 

  8. Lewis, W. (2003). Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy. Prog. Cardiovasc. Dis. 45: 305–318.

    Article  PubMed  CAS  Google Scholar 

  9. Dagan, T., Sable, C., Bray, J., and Gerschenson, M. (2002). Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence? Mitochondrion 1: 397–412.

    Article  PubMed  CAS  Google Scholar 

  10. Domanski M.J., Sloas, M.M., Follmann, D.A., Scalise, P.P. 3rd, Tucker, E.E., Egan, D., et al. (1995). Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J. Pediatr. 127:137–146.

    Article  PubMed  CAS  Google Scholar 

  11. Walker, D.M., Rucher, R., Funk, K., Hardisty, J.H., and Walker, V.E. (2004). Transplacental carcinogenicity of 3′-azido-3′-deoxythymine in B6C3F1 mice and F344 rats. Toxicologist 73(S-1):113.

    Google Scholar 

  12. Seligman, A.M., Karnovsky, M.J., Wasserkrug, H.L., and Hanker, J.S. (1968). Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J. Cell Biol. 38:1–14.

    Article  PubMed  CAS  Google Scholar 

  13. Lund, A.K., Goens, M.B., Kanagy, N.L., and Walker, M.K. (2003). Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicol. Appl. Pharmacol. 193:177–187.

    Article  PubMed  CAS  Google Scholar 

  14. Ghadially, F.N. (1997). Ultrastructural pathology of the cell and matrix, 4th ed. Vol. 1 Butterworth-Heinemann, Boston.

    Google Scholar 

  15. Poirier, M., Olivero, O., Walker, D., and Walker, V. (2004). Perinatal genotoxicity and carcinogenicity of the antiretroviral nucleoside analog drugs. Toxicol. Appl. Pharmacol., in press.

  16. Venerosi, A., Valanzano, A., Alleva, E., and Calamandrei, G. (2001). Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT)+ lamivudine (3TC) treatment in mice. Teratology 63:26–37.

    Article  PubMed  CAS  Google Scholar 

  17. Miller, T.L., Easley, K.A., Zhang, W., Orav, E.J., Bier, D.M., Luder, E., et al. (2001). Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics 108:1287–1296.

    Article  PubMed  CAS  Google Scholar 

  18. Culnane, M., Fowler, M., Lee, S.S., McSherry, G., Brady, M., O'Donnell, K., et al. (1999). Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 281: 151–157.

    Article  PubMed  CAS  Google Scholar 

  19. Blanche, S., Tardieu, M., Rustin, P., Slama, A., Barret, B., Firtion, G., et al. (1999). Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354:1084–1089.

    Article  PubMed  CAS  Google Scholar 

  20. Lipshultz, S.E., Easley, K.A., Orav, E.J., Kaplan, S., Starc, T.J., Bricker, J.T., et al. (2000). Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N. Engl. J. Med. 343:759–766.

    Article  PubMed  CAS  Google Scholar 

  21. Lipshultz, S.E., Easley, K.A., Orav, E.J., Kaplan, S., Starc, T.J., Bricker, J.T., et al. (2002). Cardiovascular status of infants and children of women infected with HIV-1 (P(2) C(2) HIV): a cohort study. Lancet 360:368–373.

    Article  PubMed  Google Scholar 

  22. Lewis, W., Grupp, I., Grupp, G., Hoit, B., Morris, R., Samarel, A.M., et al. (2000). Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine. Lab. Invest. 80:187–197.

    Article  PubMed  CAS  Google Scholar 

  23. Szabados, E., Fischer, G.M., Toth, K., Csete, B., Nemeti, B., Trombitas, K., et al. (1999). Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic. Biol. Med. 26:309–317.

    Article  PubMed  CAS  Google Scholar 

  24. Lamperth, L., Dalakas, M.C., Dagani, F., Anderson, J., and Ferrari, R. (1991). Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest. 65: 742–751.

    PubMed  CAS  Google Scholar 

  25. Cazzalini, O., Lazze, M.C., Iamele, L., Stivala, L.A., Bianchi, L., Vaghi, P., et al. (2001). Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes. Biochem. Pharmacol. 62:893–902.

    Article  PubMed  CAS  Google Scholar 

  26. Gerschenson, M., Erhart, S.W., Paik, C.Y., St Claire, M.C., Nagashima, K., Skopets, B., et al. (2000). Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido-3′-deoxythymidine. AIDS Res. Hum. Retroviruses 16:635–644.

    Article  PubMed  CAS  Google Scholar 

  27. Gerschenson, M., Nguyen, V., Ewings, E.L., Ceresa, A., Shaw, J.A., St. Claire, M.C., et al. (2004). Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to Zidovudine plus Lamivudine. AIDS Res. Hum. Retroviruses 20:91–100.

    Article  PubMed  CAS  Google Scholar 

  28. Bialkowska, A., Bialkowski, K., Gerschenson, M., Diwan, B.A., Jones, A.B., Olivero, O.A., et al. (2000). Oxidative DNA damage in fetal tissues after transplacental exposure to 3′-azido-3′-deoxythymidine (AZT). Carcinogenesis 21: 1059–1062.

    Article  PubMed  CAS  Google Scholar 

  29. Divi, R.L., Walker, V.E., Wade, N.A., Nagashima, K., Seilkop, S.K., Adams, M.E., et al. (2004). Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS 18:1013–1021.

    Article  PubMed  CAS  Google Scholar 

  30. Yerroum, M., Pham-Dang, C., Authier, F.J., Monnet, I., Gherardi, R., and Chariot, P. (2000). Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits. Acta Neuropathol. (Berl) 100:82–86.

    Article  CAS  Google Scholar 

  31. Benbrik, E., Chariot, P., Bonavaud, S., Ammi-Said, M., Frisdal, E., Rey, C., et al. (1997). Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J. Neurol. Sci. 149:19–25.

    Article  PubMed  CAS  Google Scholar 

  32. Chantrel-Groussard, K., Delpy, L., Ratinaud, M.H., and Cogne, M. (2001). Characterization of the murine gene for subunit VIIaL of cytochrome c oxidase. C. R. Acad. Sci. III 324:1117–1123.

    PubMed  CAS  Google Scholar 

  33. Fosslien, E. (2003). Review: mitochondrial medicine—cardiomyopathy caused by defective oxidative phosphorylation. Ann. Clin. Lab. Sci. 33:371–395.

    PubMed  CAS  Google Scholar 

  34. Zeviani, M., Spinazzola, A., and Carelli, V. (2003). Nuclear genes in mitochondrial disorders. Curr.Opin. Genet. Dev. 13:262–270.

    Article  PubMed  CAS  Google Scholar 

  35. de la Asuncion, J.G., del Olmo, M.L., Sastre, J., Millan, A., Pellin, A., Pallardo, F.V., et al. (1998). AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J. Clin. Invest. 102:4–9.

    PubMed  Google Scholar 

  36. Olivero, O.A., Anderson, L.M., Diwan, B.A., Haines, D.C., Harbaugh, S.W., Moskal, T.J., et al. (1997). Transplacental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J. Natl. Cancer. Inst. 89:1602–1608.

    Article  PubMed  CAS  Google Scholar 

  37. Jacobs, H.T. (2003). Disorders of mitochondrial protein synthesis. Hum. Mol. Genet. 12 Spec No 2:R293-R301.

    Article  PubMed  CAS  Google Scholar 

  38. Meyers, R.M., Fischer, S.G., Maniatis, T., and Lerman, L.S. (1985). Modification of the melting properties of duplex determined by denaturing gradient gel electrophoresis. Nucl. Acids Res. 133:3111–3129.

    Article  Google Scholar 

  39. Michikawa, Y., Hofhaus, G., Lerman, L.S., and Attardi, G. (1997). Comprehensive, rapid and sensitive detection of sequence variants of human mitochondrial tRNA genes. Nucleic Acids Res. 25:2455–2463.

    Article  PubMed  CAS  Google Scholar 

  40. Lebrecht, D., Setzer, B., Ketelsen, U.P., Haberstroh, J., and Walker, U.A. (2003). Time dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 108: 2423–2429.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CDI Section, National Cancer Institute, NIH, Bethesda, MD

    Miriam C. Poirier & Rao L. Divi

  2. SAIC, National Cancer Institute at Frederick, Frederick, MD

    Kunio Nagashima

  3. College of Pharmacy, University of New Mexico, Albuquerque, NM

    Amie K. Lund

  4. Lovelace Respiratory Research Institute, 2425 Ridgecrest Drive SE, 87108, Albuquerque, NM

    Dale M. Walker, Matthew J. Campen, Dennis L. Cook Jr., Patsy Y. Cossey, Fletcher F. Hahn & Vernon E. Walker

Authors
  1. Dale M. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miriam C. Poirier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew J. Campen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dennis L. Cook Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rao L. Divi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kunio Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Amie K. Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Patsy Y. Cossey
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Fletcher F. Hahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Vernon E. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vernon E. Walker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walker, D.M., Poirier, M.C., Campen, M.J. et al. Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine. Cardiovasc Toxicol 4, 133–153 (2004). https://doi.org/10.1385/CT:4:2:133

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/CT:4:2:133

Key Words

Search

Navigation